Climb Bio Inc.

NASDAQ: CLYM · Real-Time Price · USD
1.93
0.21 (12.21%)
At close: Aug 15, 2025, 3:59 PM
1.92
-0.55%
After-hours: Aug 15, 2025, 07:44 PM EDT

Climb Bio Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-73.9M -35.12M -45.24M -47.48M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
5.56M 12.81M 6.99M 3.74M
Other Working Capital
2.84M 4.45M 863K -4.49M
Other Non-Cash Items
51.08M -2.05M 674K 11.84M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.7M 3.76M 210K -4.17M
Operating Cash Flow
-15.56M -20.6M -37.37M -36.07M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-132.2M -58.45M -87.96M -114.97M
Sales Maturities Of Investments
20.75M 127.43M 122.4M n/a
Other Investing Acitivies
-9.64M n/a n/a n/a
Investing Cash Flow
-121.09M 68.98M 34.44M -114.97M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
10.98M n/a n/a 149K
Financial Cash Flow
130.73M 841K n/a 177.23M
Net Cash Flow
-5.88M 49.53M -3.34M 26.43M
Free Cash Flow
-15.56M -20.6M -37.37M -36.07M